Reich, Heather N.
6 papers on CoChatORCID 0000-0001-8951-5518
Most cited papers
- Verified
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
Cherney, D. Z. I., Dekkers, C. C. J., Barbour, S. J., Cattran, D., Abdul Gafor, A. H., Greasley, P. J., Laverman, G. D., Lim, S. K., Di Tanna, G. L., Reich, H. N., et al. (2020) · The Lancet Diabetes & Endocrinology
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 283
- Verified
The pathogenesis of IgA nephropathy and implications for treatment
Cheung, C. K., Alexander, S., Reich, H. N., Selvaskandan, H., Zhang, H., & Barratt, J. (2025) · Nature Reviews Nephrology
Renal Diseases and GlomerulopathiesComplement system in diseases
Cited by 222
- Verified
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Rovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025) · Kidney International
Renal Diseases and GlomerulopathiesVasculitis and related conditions
Cited by 206
- Verified
Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus
Li, T., Prokopec, S. D., Morrison, S., Lou, W., Reich, H., Gladman, D., Urowitz, M., Scholey, J., Fortin, P. R., Boutros, P. C., et al. (2015) · Rheumatology
Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases
Cited by 49
- Verified
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
Heerspink, H. J. L., Jardine, M. J., Kohan, D. E., Lafayette, R., Levin, A., Liew, A., Zhang, H., Noronha, I. L., Mastroianni-Kirsztajn, G., Chow, S., et al. (2026) · The Lancet
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 12
- Verified
Individualised treatment effects of corticosteroids in IgA nephropathy
Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free